glycyrrhizic acid has been researched along with Subarachnoid Hemorrhage in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, X; Jing, Z; Li, Y; Sun, F; Wan, L; Wang, X | 1 |
| Chen, G; Dou, Y; Feng, D; Li, H; Liu, C; Shen, H; Sun, L; Sun, Q; Tian, X; Wang, Z; Zhou, F | 1 |
| Ieong, C; Ma, J; Sun, H; Wang, Q | 1 |
| Hang, CH; Hu, YC; Li, S; Li, W; Sun, Q; Wang, F; Zhou, M; Zhu, JH | 1 |
| Chang, CZ; Kwan, AL; Wu, SC | 2 |
6 other study(ies) available for glycyrrhizic acid and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Glycyrrhizic acid exerts anti-inflammatory effect to improve cerebral vasospasm secondary to subarachnoid hemorrhage in a rat model.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Glycyrrhizic Acid; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2017 |
HMGB1 promotes neurovascular remodeling via Rage in the late phase of subarachnoid hemorrhage.
Topics: Animals; Benzamides; Brain; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Doublecortin Protein; Glycyrrhizic Acid; HMGB1 Protein; Male; Neurons; Pyruvates; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Recombinant Proteins; Signal Transduction; Subarachnoid Hemorrhage; Vascular Remodeling | 2017 |
Glycyrrhizin suppresses the expressions of HMGB1 and ameliorates inflammative effect after acute subarachnoid hemorrhage in rat model.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Blood-Brain Barrier; Blotting, Western; Brain; Glycyrrhizic Acid; HMGB1 Protein; In Situ Nick-End Labeling; Inflammation; Male; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage | 2018 |
Glycyrrhizic acid confers neuroprotection after subarachnoid hemorrhage via inhibition of high mobility group box-1 protein: a hypothesis for novel therapy of subarachnoid hemorrhage.
Topics: Glycyrrhizic Acid; HMGB1 Protein; Humans; Models, Biological; Neuroprotective Agents; Subarachnoid Hemorrhage | 2013 |
Glycyrrhizin attenuates Toll like receptor-2, -4 and experimental vasospasm in a rat model.
Topics: Animals; Anti-Inflammatory Agents; Basilar Artery; Chemokine CCL2; Cytokines; Disease Models, Animal; Gene Expression; Glycyrrhizic Acid; Male; Rats; Subarachnoid Hemorrhage; Toll-Like Receptor 2; Toll-Like Receptor 3; Toll-Like Receptor 4; Vasospasm, Intracranial | 2014 |
Glycyrrhizin Attenuates Proinflammatory Cytokines through a Peroxisome Proliferator-Activated Receptor-γ-Dependent Mechanism and Experimental Vasospasm in a Rat Model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Basilar Artery; Cytokines; Drugs, Chinese Herbal; Endothelium, Vascular; Gene Expression Regulation; Glycyrrhizic Acid; Inflammation; Infusion Pumps; Male; Phytotherapy; PPAR delta; PPAR gamma; Premedication; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Single-Blind Method; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2015 |